Skip to main content
. 2020 Feb 7;9(3):143–152. doi: 10.1002/psp4.12490

Figure 3.

Figure 3

The percentage of patients achieving 30% shrinkage in sum of longest diameters. CHEMO, chemotherapy; EGFR−, epidermal growth factor receptor negative; EGFR+, epidermal growth factor receptor positive; GEFI, gefitinib.